CILP
Basic information
Region (hg38): 15:65194760-65211473
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CILP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 89 | 97 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 90 | 8 | 7 |
Variants in CILP
This is a list of pathogenic ClinVar variants found in the CILP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-65196790-C-T | CILP-related disorder | Benign (Oct 16, 2019) | ||
15-65196835-G-T | not specified | Uncertain significance (Dec 13, 2021) | ||
15-65196910-G-A | not specified | Uncertain significance (Apr 05, 2023) | ||
15-65196919-G-C | not specified | Uncertain significance (Feb 13, 2024) | ||
15-65196945-G-C | not specified | Uncertain significance (Sep 01, 2021) | ||
15-65196948-A-G | Uncertain significance (-) | |||
15-65197052-A-G | CILP-related disorder | Likely benign (May 24, 2019) | ||
15-65197062-C-T | not specified | Uncertain significance (May 31, 2023) | ||
15-65197096-G-A | Benign (Aug 03, 2017) | |||
15-65197117-C-T | not specified | Uncertain significance (Nov 21, 2022) | ||
15-65197185-C-T | not specified | Likely benign (Aug 22, 2023) | ||
15-65197186-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
15-65197231-G-A | not specified | Uncertain significance (Dec 02, 2022) | ||
15-65197231-G-C | not specified | Uncertain significance (Mar 04, 2024) | ||
15-65197251-C-T | not specified | Uncertain significance (May 26, 2024) | ||
15-65197278-G-T | not specified | Uncertain significance (Jun 22, 2023) | ||
15-65197305-C-T | not specified | Uncertain significance (Nov 18, 2022) | ||
15-65197306-G-A | not specified | Uncertain significance (Dec 04, 2023) | ||
15-65197345-C-T | not specified | Uncertain significance (Jul 17, 2023) | ||
15-65197350-T-C | CILP-related disorder | Benign (Jan 02, 2020) | ||
15-65197367-C-T | not specified | Uncertain significance (May 27, 2022) | ||
15-65197479-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
15-65197527-T-C | Uncertain significance (-) | |||
15-65197588-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
15-65197693-C-T | not specified | Uncertain significance (Jan 31, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CILP | protein_coding | protein_coding | ENST00000261883 | 8 | 15490 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.37e-26 | 0.000323 | 125492 | 3 | 253 | 125748 | 0.00102 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.170 | 693 | 706 | 0.982 | 0.0000418 | 7772 |
Missense in Polyphen | 332 | 339.52 | 0.97786 | 3706 | ||
Synonymous | 0.573 | 258 | 270 | 0.956 | 0.0000147 | 2404 |
Loss of Function | 0.0626 | 39 | 39.4 | 0.989 | 0.00000215 | 451 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00256 | 0.00255 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.00191 | 0.00180 |
Finnish | 0.000372 | 0.000370 |
European (Non-Finnish) | 0.000795 | 0.000783 |
Middle Eastern | 0.00191 | 0.00180 |
South Asian | 0.00184 | 0.00170 |
Other | 0.00213 | 0.00212 |
dbNSFP
Source:
- Function
- FUNCTION: Probably plays a role in cartilage scaffolding. May act by antagonizing TGF-beta1 (TGFB1) and IGF1 functions. Has the ability to suppress IGF1-induced proliferation and sulfated proteoglycan synthesis, and inhibits ligand-induced IGF1R autophosphorylation. May inhibit TGFB1-mediated induction of cartilage matrix genes via its interaction with TGFB1. Overexpression may lead to impair chondrocyte growth and matrix repair and indirectly promote inorganic pyrophosphate (PPi) supersaturation in aging and osteoarthritis cartilage. {ECO:0000269|PubMed:12746903, ECO:0000269|PubMed:15864306}.;
- Disease
- DISEASE: Intervertebral disc disease (IDD) [MIM:603932]: A common musculo-skeletal disorder caused by degeneration of intervertebral disks of the lumbar spine. It results in low-back pain and unilateral leg pain. {ECO:0000269|PubMed:15864306}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. {ECO:0000269|PubMed:15864306}.;
- Pathway
- Signal Transduction;Signaling by Receptor Tyrosine Kinases;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
(Consensus)
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- loftool
- 0.980
- rvis_EVS
- -1.53
- rvis_percentile_EVS
- 3.34
Haploinsufficiency Scores
- pHI
- 0.251
- hipred
- N
- hipred_score
- 0.216
- ghis
- 0.529
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.376
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Cilp
- Phenotype
Gene ontology
- Biological process
- negative regulation of gene expression;dephosphorylation;negative regulation of insulin-like growth factor receptor signaling pathway;negative regulation of SMAD protein signal transduction;cellular response to transforming growth factor beta stimulus
- Cellular component
- extracellular space;collagen-containing extracellular matrix;extracellular exosome
- Molecular function
- alkaline phosphatase activity;nucleotide diphosphatase activity;extracellular matrix structural constituent